KROS
Keros Therapeutics, Inc. Common Stock
$11.44
0.00%
0.00
Notify me if price changes either direction
Buy KROS stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
348.5M
Enterprise value
-47526700
Trailing PE
4.978261
Forward PE
-2.2658327
PEG Ratio
-0.20268634071429
Enterprise to EBITDA
-0.659
Enterprise to revenue
-0.195
Price to book MRQ
0.7382334
Price to sales TTM
1.4293004
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2025-12-31
Revenue (TTM)
244.1M
EBITDA
44.2M
Diluted EPS TTM
2.3
Total Cash (MRQ)
287.4M
Current ratio (MRQ)
15.452
Operating Cash Flow (TTM)
107.5M
KROS trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
April 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
